Jim Simons Sight Sciences, Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 393,006 shares of SGHT stock, worth $994,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares

393,006

Previous 52,100 654.33%

Holding current value

$994,305

Previous $328,000 335.98%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$3.36 - $6.18 $1.15 Million - $2.11 Million	340,906 Added 654.33%	393,006 $1.43 Million
Q3 2024 Nov 13, 2024	SELL	$5.49 - $8.31 $93,330 - $141,270	-17,000 Reduced 24.6%	52,100 $328,000
Q2 2024 Aug 09, 2024	SELL	$5.13 - $7.15 $541,502 - $754,725	-105,556 Reduced 60.44%	69,100 $460,000
Q1 2024 May 13, 2024	BUY	$4.02 - $5.89 $390,969 - $572,837	97,256 Added 125.65%	174,656 $922,000
Q4 2023 Feb 13, 2024	BUY	$1.29 - $5.86 $14,706 - $66,804	11,400 Added 17.27%	77,400 $399,000
Q3 2023 Nov 14, 2023	BUY	$2.88 - $8.8 $146,016 - $446,160	50,700 Added 331.37%	66,000 $222,000
Q2 2023 Aug 11, 2023	BUY	$7.46 - $10.67 $114,138 - $163,251	15,300 New	15,300 $127,000
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $20,044 - $37,493	3,286 Added 11.61%	31,586 $201,000
Q2 2022 Aug 12, 2022	SELL	$6.61 - $11.99 $4,627 - $8,393	-700 Reduced 2.41%	28,300 $254,000
Q1 2022 May 13, 2022	SELL	$11.56 - $17.9 $235,824 - $365,160	-20,400 Reduced 41.3%	29,000 $335,000
Q4 2021 Feb 11, 2022	BUY	$17.36 - $27.36 $857,584 - $1.35 Million	49,400 New	49,400 $868,000

Others Institutions Holding SGHT

# of Institutions

Shares Held

22.4M

Call Options Held

62.8K

Put Options Held

900

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $121M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account